| 查看: 646 | 回复: 1 | ||
| 【奖励】 本帖被评价1次,作者lwjxz增加金币 0.8 个 | ||
[资源]
2011.07.21~22生物利用度/生物等效性(BA/BE)国际高级研习班(苏州)资料3 PDF版
|
||
|
培训班授课专家介绍: 3. DUXIN SUN Ph.D., College of Pharmacy, University of Michigan Dr. Duxin Sun is an Associate Professor in the Department of Pharmaceutical Sciences, College of Pharmacy, The University of Michigan. He received his Ph.D. degree in Pharmaceutics, MS degree in Pharmacology, and a BS degree in Pharmacy. From 2003-2008, Dr. Sun was an Assistant Professor in the College of Pharmacy, The Ohio State University. From 2002-2003, Dr. Sun worked in Bristol-Myers Squibb Company as a research investigator in drug delivery, drug absorption and pharmacokinetics. From 1994 -1998, Dr. Sun was a visiting scholar and senior research specialist in the Department of Pharmacology at Vanderbilt University and the University of Pennsylvania. Dr. Sun has broad background in his research including Pharmaceutical Sciences, Pharmacology, Molecular Biology, and Pharmacy. Dr. Sun has broad research interests in therapeutics and chemoprevention of cancers and cancer stem cells, “nanotheranostics” for cancer imaging and drug delivery, and pharmacokinetics. Dr. Sun’s research is supported by NIH, FDA, and other agencies. Dr. Sun has published actively in peer-reviewed journals with more than 85 published papers, 58 meeting abstracts, 7 book chapters, and 7 US patents. Dr. Sun severed as study section members for many grant agencies such as NIH, FDA, Cancer Research UK, French National Research Agency, and Italian Ministry of Health. Dr. Sun served as the Vice Chair, Chair-Elect, and Chair of PPB section in AAPS (2008-2011), Chair of Prodrug Focus Group in AAPS (2007-2008), Co-chairs of various symposia in AAPS annual meeting from 2003-2009. Dr. Sun is a member of American Association of Pharmaceutical Scientist (AAPS), American Association of Cancer Research (AACR), and American Association of College of Pharmacy (AACP). 影响药物吸收、生物利用度和生物等效性的因素--孙笃新(2011.07.21).pdf 下载:http://ishare.iask.sina.com.cn/f/17784462.html [ Last edited by lwjxz on 2011-8-6 at 11:34 ] |
» 猜你喜欢
消耗微量API,便可预测早期研发阶段的HME工艺可行性
已经有0人回复
反应液中苯酐除去
已经有1人回复
药理学论文润色/翻译怎么收费?
已经有121人回复
扩散模型生成分子目前痛点,改进方向有哪些,论文创新性卡住了现在
已经有0人回复
求解答药物生成模型痛点以及创新点,扩散模型创新
已经有0人回复
【讨论】油脂性API、液体API及中药提取物直压解决方案--合成硅酸钙
已经有1人回复
一篇关于阿莫西林克拉维酸钾的文献
已经有1人回复
南方医科大学创面修复方向招博士研究生
已经有0人回复
科研好物分享:Tguide® tLNP 对照试剂盒
已经有0人回复
【试剂分享】告别微流控:预制 Mal-LN29-tLNP 抗体偶联试剂盒,脾脏 CD8+ 转染 97.2%
已经有6人回复
【试剂分享】告别微流控:预制 Mal-LN29-tLNP 抗体偶联试剂盒,脾脏 CD8+ 转染 97.2%
已经有0人回复
» 本主题相关价值贴推荐,对您同样有帮助:
2楼2011-08-06 23:58:28










回复此楼